Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105732413B reveals ligand-free copper catalysis for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101875666A details a novel asymmetric synthesis route for high-purity Dapoxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101010293A reveals a novel salt formation method for high-purity chiral 3-halophthalic acid derivatives, solving isomer separation issues in agrochemical intermediate manufacturing.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN116041216A reveals a high-yield Pd-catalyzed asymmetric C-H arylation method. This breakthrough offers reliable pharmaceutical intermediate suppliers a scalable route for chiral amides with superior enantioselectivity.